Navigation Links
Chemists design molecules for controlling bacterial behavior
Date:5/13/2014

Chemists in the College of Arts and Sciences have figured out how to control multiple bacterial behaviorspotentially good news for the treatment of infectious diseases and other bacteria-associated issues, without causing drug resistance.

Yan-Yeung Luk, associate professor of chemistry, has spearheaded the discovery, in conjunction with his research lab at Syracuse University and the Wang Lab at SUNY Upstate Medical University. Their findings are the subject of a forthcoming article in the journal ChemBioChem (John Wiley & Sons Inc.).

"Since the discovery of the first antibiotic, penicillin, in 1928, bacteria have become smarter and have developed resistance to many drugs," says Luk, an expert in bio-organic chemistry, nanomaterials and chemical biology. "They've done this by altering their genetic make-up; transferring drug-resistant genes between one another; and creating biofilms, which are multicellular communities where bacteria can be a thousand-fold more resistant to antibiotics."

In response, Luk's team has developed a class of chemical agents that does not kill bacteria but, rather, changes their multicellular behaviors. These agents are called disaccharide derivatives, and they mimic a class of natural molecules known as rhamnolipids, which are produced and secreted by the bacterium itself.

Luk says that while non-microbicidal (i.e., "non-killing") molecules are nothing new, his are unique because they target a new, yet-to-be-explained set of biological receptors.

"Rhamnolipids modulate at least three multicellular bioactivities in Pseudomonas aeruginosa," says Luk, referring to the rod-shaped bacterium that causes disease in animals and humans. "The synthetic molecules made by our lab don't exactly look like rhamnolipids, but they can control bioactivities, such as swarming movements, surface adhesion and biofilm formation."

This class, he adds, is non-microbicidal with a wide variety of microbes, thus giving it broad commercial value. It also has the potential to inhibit horizontal gene transferthe process by which bacteria share genetic information, such as the ability to be drug-resistant.

In the near future, Luk's team plans to unveil another class of molecules they have designed that not only mimics but also dominates the activities of rhamnolipids.

"Rhamnolipids are already on the market, but our product, with its synthetic flexibility, has just as many applications and may be improved rationally by synthetic design," says Luk, who also holds courtesy appointments in the Department of Biology in the College of Arts and Sciences and in the Department of Biomedical and Chemical Engineering in the College of Engineering and Computer Science. "All of this is subject to ongoing research."


'/>"/>

Contact: Rob Enslin
rmenslin@syr.edu
315-443-3403
Syracuse University
Source:Eurekalert  

Related biology news :

1. Inspired by moth eyeballs, UC Irvine chemists develop gold coating that dims glare
2. Chemists work with small peptide chains may revolutionize study of enzymes and diseases
3. Notre Dame chemists discover new class of antibiotics
4. Mentoring the next generation of black chemists (video)
5. CCNY chemists use sugar-based gelators to solidify vegetable oils
6. Biochemists find incomplete protein digestion is a useful thing for some bacteria
7. CCNY chemists devise new way to prepare molecules for drug testing
8. Biochemists uphold law of physics
9. University of Wisconsin chemists find new compounds to curb staph infection
10. UCI chemists devise inexpensive, accurate way to detect prostate cancer
11. Chemists devise inexpensive, benchtop method for marking and selecting cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemists design molecules for controlling bacterial behavior
(Date:1/25/2016)... SEATTLE , Jan. 25, 2016  Glencoe Software, ... biotech, pharma and publication industries, will provide the data ... Phenotypic Screening Centre (NPSC). ... Phenotypic analysis ... even whole organisms, allowing comparisons between states such as ...
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
(Date:1/13/2016)... , January 13, 2016 ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ... ) has announced the addition of ... Market - Estimation & Forecast (2015-2020)" ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... DIEGO, Feb. 11, 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... ended December 31, 2015. --> ... a net loss of $29.3 million, or $0.34 loss per share, ... per share for the same period in 2014. For the year ... $88.9 million, or $1.05 loss per share, as compared to a ...
(Date:2/11/2016)... , Germany and ... QGEN ; Frankfurt Prime Standard: QIA) today ... Targeted RNA Panels for gene expression profiling, expanding QIAGEN,s ... (NGS). The panels enable researchers to select from over ... changes and discover interactions between genes, cellular phenotypes and ...
(Date:2/11/2016)... 2016  Spectra BioPharma Selling Solutions (Spectra) is ... biopharma companies the experience, expertise, operational delivery and ... sales teams. Created in concert with industry leading ... strategic and tactical needs of its clients by ... both personal and non-personal promotion. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... dedicated to delivering cutting-edge information focused on the development and manufacture of ... become a premier sponsor of the 2016 BioProcess International Awards – Recognizing ...
Breaking Biology Technology: